Practical approaches for the treatment of chronic heart failure: Frequently asked questions, overlooked points and controversial issues in current clinical practice

Anatol J Cardiol. 2015 Oct:15 Suppl 2:1-60. doi: 10.5152/AnatolJCardiol.2015.6767.

Abstract

Heart failure (HF) is a progressive disorder associated with impaired quality of life, high morbidity, mortality and frequent hospitalization and affects millions of people from all around the world. Despite further improvements in HF therapy, mortality and morbidity remains to be very high. The life-long treatment, frequent hospitalization, and sophisticated and very expensive device therapies for HF also leads a substantial economic burden on the health care system. Therefore, implementation of evidence-based guideline-recommended therapy is very important to overcome its worse clinical outcomes. However, HF therapy is a long process that has many drawbacks and sometimes HF guidelines cannot answers to every question which rises in everyday clinical practice. In this paper, commonly encountered questions, overlooked points, controversial issues, management strategies in grey zone and problems arising during follow up of a HF patient in real life clinical practice have been addressed in the form of expert opinions based on the available data in the literature.

Publication types

  • Case Reports

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Anemia / complications
  • Anemia / drug therapy
  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Atrial Fibrillation / drug therapy
  • Cardiovascular Agents / therapeutic use
  • Chronic Disease
  • Diabetes Mellitus / drug therapy
  • Diuretics / therapeutic use
  • Evidence-Based Medicine
  • Female
  • Heart Failure / complications
  • Heart Failure / drug therapy
  • Heart Failure / therapy*
  • Humans
  • Hypertension / drug therapy
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / drug therapy
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Practice Guidelines as Topic*
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / drug therapy
  • Pulmonary Disease, Chronic Obstructive / complications
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Renal Insufficiency, Chronic / drug therapy
  • Turkey

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiovascular Agents
  • Diuretics
  • Mineralocorticoid Receptor Antagonists